BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

831 related articles for article (PubMed ID: 26008591)

  • 1. Regulation of tumour necrosis factor signalling: live or let die.
    Brenner D; Blaser H; Mak TW
    Nat Rev Immunol; 2015 Jun; 15(6):362-74. PubMed ID: 26008591
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TNF and ROS Crosstalk in Inflammation.
    Blaser H; Dostert C; Mak TW; Brenner D
    Trends Cell Biol; 2016 Apr; 26(4):249-261. PubMed ID: 26791157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The survival effect of TNF-alpha in human neutrophils is mediated via NF-kappa B-dependent IL-8 release.
    Cowburn AS; Deighton J; Walmsley SR; Chilvers ER
    Eur J Immunol; 2004 Jun; 34(6):1733-43. PubMed ID: 15162444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Signalling pathways of the TNF superfamily: a double-edged sword.
    Aggarwal BB
    Nat Rev Immunol; 2003 Sep; 3(9):745-56. PubMed ID: 12949498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of TNF/TNFR in autoimmunity: specific TNF receptor blockade may be advantageous to anti-TNF treatments.
    Kollias G; Kontoyiannis D
    Cytokine Growth Factor Rev; 2002; 13(4-5):315-21. PubMed ID: 12220546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumour necrosis factor signalling in health and disease.
    Holbrook J; Lara-Reyna S; Jarosz-Griffiths H; McDermott M
    F1000Res; 2019; 8():. PubMed ID: 30755793
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of nuclear factor-kappaB activation is essential for membrane-associated TNF-alpha-induced apoptosis in HL-60 cells.
    Shi W; Li L; Shi X; Zheng F; Zeng J; Jiang X; Gong F; Zhou M; Li Z
    Immunol Cell Biol; 2006 Aug; 84(4):366-73. PubMed ID: 16594899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cellular sources of pathogenic and protective TNF and experimental strategies based on utilization of TNF humanized mice.
    Winsauer C; Kruglov AA; Chashchina AA; Drutskaya MS; Nedospasov SA
    Cytokine Growth Factor Rev; 2014 Apr; 25(2):115-23. PubMed ID: 24405806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TNF receptor signalling in autoinflammatory diseases.
    Jarosz-Griffiths HH; Holbrook J; Lara-Reyna S; McDermott MF
    Int Immunol; 2019 Sep; 31(10):639-648. PubMed ID: 30838383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential target of infliximab in autoimmune and inflammatory diseases.
    Atzeni F; Doria A; Carrabba M; Turiel M; Sarzi-Puttini P
    Autoimmun Rev; 2007 Sep; 6(8):529-36. PubMed ID: 17854744
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intracellular regulation of TNF activity in health and disease.
    Varfolomeev E; Vucic D
    Cytokine; 2018 Jan; 101():26-32. PubMed ID: 27623350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Role of Tumor Necrosis Factor Alpha (TNF-α) in Autoimmune Disease and Current TNF-α Inhibitors in Therapeutics.
    Jang DI; Lee AH; Shin HY; Song HR; Park JH; Kang TB; Lee SR; Yang SH
    Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33800290
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The regulation of TNF signalling: what a tangled web we weave.
    Silke J
    Curr Opin Immunol; 2011 Oct; 23(5):620-6. PubMed ID: 21920725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synergistic effect of interleukin-17 and tumour necrosis factor-α on inflammatory response in hepatocytes through interleukin-6-dependent and independent pathways.
    Beringer A; Thiam N; Molle J; Bartosch B; Miossec P
    Clin Exp Immunol; 2018 Aug; 193(2):221-233. PubMed ID: 29676779
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transmembrane tumour necrosis factor is neuroprotective and regulates experimental autoimmune encephalomyelitis via neuronal nuclear factor-kappaB.
    Taoufik E; Tseveleki V; Chu SY; Tselios T; Karin M; Lassmann H; Szymkowski DE; Probert L
    Brain; 2011 Sep; 134(Pt 9):2722-35. PubMed ID: 21908876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of the TNF-alpha autocrine-paracrine loop, via NF-kappaB and YY1, in the regulation of tumor cell resistance to Fas-induced apoptosis.
    Huerta-Yepez S; Vega M; Garban H; Bonavida B
    Clin Immunol; 2006 Sep; 120(3):297-309. PubMed ID: 16784892
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TNFR2 increases the sensitivity of ligand-induced activation of the p38 MAPK and NF-κB pathways and signals TRAF2 protein degradation in macrophages.
    Ruspi G; Schmidt EM; McCann F; Feldmann M; Williams RO; Stoop AA; Dean JL
    Cell Signal; 2014 Apr; 26(4):683-90. PubMed ID: 24378531
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Immune regulation role of A20 and its clinical significance].
    Li YQ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Aug; 19(4):851-6. PubMed ID: 21867600
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TRAF2 multitasking in TNF receptor-induced signaling to NF-κB, MAP kinases and cell death.
    Borghi A; Verstrepen L; Beyaert R
    Biochem Pharmacol; 2016 Sep; 116():1-10. PubMed ID: 26993379
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of the two TNF receptors in proliferation, NF-kappa B activation and discrimination between TNF and LT alpha signalling in the human myeloma cell line OH-2.
    Börset M; Medvedev AE; Sundan A; Espevik T
    Cytokine; 1996 Jun; 8(6):430-8. PubMed ID: 8818539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 42.